Bristol Myers beats $6.4 billion lawsuit over delayed cancer drug

(Reuters) – Bristol Myers Squibb won the dismissal on Monday of a $6.4 billion lawsuit claiming it cheated former Celgene shareholders by delaying federal approval for the cancer drug Breyanzi and two other drugs developed by Celgene. U.S. District Judge Jesse Furman in Manhattan said UMB Bank was never properly appointed trustee for shareholders owning…

Read More

Tesla’s quarterly deliveries set to rise as China incentives lure wary EV buyers

By Akash Sriram and Abhirup Roy (Reuters) – Tesla is expected to report an 8% jump in third-quarter deliveries of its electric vehicles on Wednesday, Wall Street estimates show, driven by extended incentives and lucrative financing plans in the world’s largest auto market, China. Responding to sluggish Chinese spending amid flagging economic growth and rising…

Read More

China says US missile deployment in Philippines undermines peace

SHANGHAI (Reuters) – Chinese Foreign Minister Wang Yi said the U.S. deployment of intermediate-range missiles in the Philippines “undermines regional peace and stability”, the foreign ministry said on Sunday. Speaking to South Korean Foreign Minister Cho Tae-yul in New York on Saturday, Wang also called for avoiding “war or chaos on the Korean Peninsula”, the…

Read More

Thyssenkrupp steel head prepares staff for ‘tough’ cuts

FRANKFURT (Reuters) – Thyssenkrupp’s 27,000 steel workers must brace for deep cuts, the new head of the conglomerate’s steel division told a German newspaper, setting the stage for significant layoffs. “Tough cuts are necessary. We have to become more profitable,” Dennis Grimm, spokesperson for Thyssenkrupp Steel Europe’s (TKSE) executive board, told Westdeutsche Allgemeine Zeitung (WAZ)…

Read More